The incorporation of drugs to treat patients with rare diseases. This was the theme of the Comitê Executivo do Fórum Nacional do Poder Judiciário. The meeting happened on June 18th at the Conselho Nacional de Justiça (CNJ) in Brasilia (DF). Otávio Clark, CEO of Evidências - Kantar Health, , attendedRead more
To understand the medicines use patterns to treat patients with bipolar disorder type I. This is the aim of the most recent study of Evidências - Kantar Health published in an international journal. The article “Systematic literature review on patterns of pharmacological treatment and adherence amongRead more
Otávio Clark, CEO of Evidências - Kantar Health highlights the study Keynote 42, presented at the Annual Congress of American Society of Clinical Oncology (ASCO) by Gilberto Lopes, oncologist Sylvester Comprehensive Cancer Center at the University of Miami. ASCO ASCO holds an annual meeting thatRead more
A slap, a push, a curse, an embarrassment, a humiliation or a threat ... Violence against women has many forms. And despite all the measures that have been taken in recent years, violence against women has epidemic proportions, representing a significant global public health problem. And that is not all: theRead more
We are a hub of healthcare solutions with the objective of solving problems through evidence-based medicine (EBM) techniques and assisting in decision making related to health technologies and market analysis. With strong leadership, our focus is to provide innovative solutions to improve global health by developing high-complexity case analysis, clinical trial design, courses and training, health technology reports, drug registration and incorporation of health technology dossiers, and economic studies. Combining passion for science with great commercial experience and deep knowledge of the Brazilian healthcare ...